![Quiver Logo](/static/img/logo-icon.png)
![HLVX logo](https://quiver-logos.s3.us-east-2.amazonaws.com/hlvx.png)
HilleVax, Inc. Common Stock
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view HLVX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of HLVX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HLVX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to HLVX
Recent picks made for HLVX stock on CNBC
ETFs with the largest estimated holdings in HLVX
Flights by private jets registered to HLVX
![Quiver Logo](/static/img/logo-icon.png)